Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29648904 | 1.00 | CYP3A4 (0.48) | CYP3A4GABRA1GABRB2TSHRALDH1A1 | |
| SCHEMBL661906 | 0.84 | CYP3A4 (0.50) | CYP3A4GABRA1GABRB2TSHRALDH1A1 | |
| SCHEMBL15544 | 0.84 | CYP3A4 (0.50) | CYP3A4GABRA1GABRB2TSHRALDH1A1 | |
| SCHEMBL29404189 | 0.84 | CYP3A4 (0.50) | CYP3A4GABRA1GABRB2TSHRALDH1A1 | |
| SCHEMBL31109186 | 0.84 | CYP3A4 (0.50) | CYP3A4GABRA1GABRB2TSHRALDH1A1 | |
| SCHEMBL18701450 | 0.84 | CYP3A4 (0.50) | CYP3A4GABRA1GABRB2TSHRALDH1A1 | |
| SCHEMBL93290 | 0.83 | GABRA1 (0.61) | CYP3A4GABRA1GABRB2TSHRALDH1A1 | |
| SCHEMBL1396494 | 0.83 | CYP3A4 (0.48) | CYP3A4GABRA1GABRB2TSHRALDH1A1 | |
| SCHEMBL29795971 | 0.83 | GABRA1 (0.61) | CYP3A4GABRA1GABRB2TSHRALDH1A1 | |
| SCHEMBL7723447 | 0.82 | GABRA1 (0.55) | CYP3A4GABRA1GABRB2TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111100732-B | Soap urethane lubricating grease and preparation method thereof | 中国石油化工股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-111100732-A | Soap urethane lubricating grease and preparation method thereof | 中国石油化工股份有限公司 | 2020-05-05 | — | — | CN | claimed |
| US-20090216006-A1 | COVALENTLY BOUND POLYSACCHARIDE-BASED CHIRAL STATIONARY PHASES AND METHOD FOR THEIR PREPARATION | XU HUI | 2009-08-27 | — | — | US | claimed |
| CN-101356165-A | Process for preparing gemcitabine and related intermediates | CHEMAGIS LTD (IL) | 2009-01-28 | — | — | CN | claimed |
| US-20070249823-A1 | PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES | CHEMAGIS LTD. (IL) | 2007-10-25 | — | — | US | claimed |
| WO-2007077457-A9 | TREATMENT OF EQUINE LAMINITIS WITH 5-HT1B/ 1D ANTAGONISTS | ROYAL VETERINARY COLLEGE (GB) | 2007-10-18 | — | — | WO | claimed |
| WO-2007077457-A2 | TREATMENT OF EQUINE LAMINITIS WITH 5-HT1B/ 1D ANTAGONISTS | THE ROYAL VETERINARY COLLEGE (GB) | 2007-07-12 | — | — | WO | claimed |
| WO-2007070804-A2 | PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES | CHEMAGIS LTD. (IL) | 2007-06-21 | — | — | WO | claimed |
| EP-0874831-A1 | PROCESSES AND COMPOUNDS FOR PREPARING CYCLIC UREA FUNGICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-11-04 | — | — | EP | claimed |
| WO-1997019935-A1 | PROCESSES AND COMPOUNDS FOR PREPARING CYCLIC UREA FUNGICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-06-05 | — | — | WO | claimed |
| US-4006170-A | MULTISTAGE FROM O-CHLOROMETHYLPHENYL ISOCYANATE AND BENZENE | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | claimed |
| JP-63275621-A | — | — | None | — | — | JP | disclosed |
| EP-4713378-A1 | ESTERIFIED ETHANOLAMINES FOR PREPARING ISOCYANURATE POLYMERS | Covestro Deutschland AG (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-3921349-B1 | PHENYL ISOCYANATE CONVERSION PROCESS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-3774961-B1 | ADDUCTS OF AMINE CATALYSTS FOR PRODUCING ISOCYANURATE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2025-01-15 | — | — | EP | disclosed |
| US-4058561-A | 2-Chloromethylphenylcarbamic acid fluoride | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-15 | — | — | US | disclosed |
| US-4058561-A | 2-Chloromethylphenylcarbamic acid fluoride | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-15 | — | — | US | disclosed |
| US-4006170-A | MULTISTAGE FROM O-CHLOROMETHYLPHENYL ISOCYANATE AND BENZENE | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
| US-4006170-A | MULTISTAGE FROM O-CHLOROMETHYLPHENYL ISOCYANATE AND BENZENE | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
| US-3910890-A | Preparation of morphanthridin-6-(5H)-ones | SANDOZ AG | 1975-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249823-A1 | PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES | DPYD, PARP1, PARP2 | CYP3A4 535/4885GABRA1 4343/4885GABRB2 4255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.